Related Experiment Videos
Managing opioid addiction with buprenorphine.
Paul A Donaher1, Christopher Welsh
1Whitsett Center, Chestertown, MD, USA.
American Family Physician
|May 25, 2006
Summary
Buprenorphine is an effective medication for treating opioid addiction in an office setting. While comparable to methadone at lower doses, it may be less effective for patients needing higher doses.
Area of Science:
- Pharmacology
- Addiction Medicine
- Public Health
Background:
- Opioid dependence is a significant public health issue.
- Legislation now permits office-based treatment for opioid addiction using buprenorphine.
- Buprenorphine is a partial mu-opioid receptor agonist used in maintenance therapy.
Purpose of the Study:
- To evaluate the efficacy of buprenorphine in managing opioid addiction.
- To compare buprenorphine's effectiveness with placebo and methadone.
- To outline the treatment phases and considerations for buprenorphine therapy.
Main Methods:
- Clinical studies were reviewed to assess buprenorphine's effectiveness.
- Treatment phases including induction, stabilization, and maintenance were analyzed.
- Dosage comparisons with methadone were considered.
Main Results:
- Buprenorphine is more effective than placebo for opioid addiction management.
- It is comparable to lower doses of methadone but may not be superior to high-dose methadone.
- Initiation during withdrawal and adjustment for cravings are key.
Conclusions:
- Buprenorphine offers an effective, low-abuse potential option for office-based opioid addiction treatment.
- Considerations include cost and potential limitations in high-dose methadone-requiring patients.
- Physician training is required for prescribing buprenorphine.